» Articles » PMID: 34853321

Nonspecific Binding of Common Anti-CFTR Antibodies in Ciliated Cells of Human Airway Epithelium

Overview
Journal Sci Rep
Specialty Science
Date 2021 Dec 2
PMID 34853321
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

There is evidence that the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel is highly expressed at the apical pole of ciliated cells in human bronchial epithelium (HBE), however recent studies have detected little CFTR mRNA in those cells. To understand this discrepancy we immunostained well differentiated primary HBE cells using CFTR antibodies. We confirmed apical immunofluorescence in ciliated cells and quantified the covariance of the fluorescence signals and that of an antibody against the ciliary marker centrin-2 using image cross-correlation spectroscopy (ICCS). Super-resolution stimulated emission depletion (STED) imaging localized the immunofluorescence in distinct clusters at the bases of the cilia. However, similar apical fluorescence was observed when the monoclonal CFTR antibodies 596, 528 and 769 were used to immunostain ciliated cells expressing F508del-CFTR, or cells lacking CFTR due to a Class I mutation. A BLAST search using the CFTR epitope identified a similar amino acid sequence in the ciliary protein rootletin X1. Its expression level correlated with the intensity of immunostaining by CFTR antibodies and it was detected by 596 antibody after transfection into CFBE cells. These results may explain the high apparent expression of CFTR in ciliated cells and reports of anomalous apical immunofluorescence in well differentiated cells that express F508del-CFTR.

Citing Articles

Bitter taste receptor T2R14-Gαi coupling mediates innate immune responses to microbial quorum sensing molecules in cystic fibrosis.

Singh N, Cunnington R, Bhagirath A, Vaishampayan A, Khan M, Gupte T iScience. 2024; 27(12):111286.

PMID: 39628561 PMC: 11613190. DOI: 10.1016/j.isci.2024.111286.


Current landscape of cystic fibrosis gene therapy.

Plasschaert L, MacDonald K, Moffit J Front Pharmacol. 2024; 15:1476331.

PMID: 39439894 PMC: 11493704. DOI: 10.3389/fphar.2024.1476331.


Pharmacological and pre-clinical safety profile of rSIV.F/HN, a hybrid lentiviral vector for cystic fibrosis gene therapy.

Moiseenko A, Sinadinos A, Sergijenko A, Pineault K, Saleh A, Nekola K Eur Respir J. 2024; 65(1).

PMID: 39174284 PMC: 11780724. DOI: 10.1183/13993003.01683-2023.


Analysis of CFTR mRNA and Protein in Peripheral Blood Mononuclear Cells via Quantitative Real-Time PCR and Western Blot.

Schnell A, Tamm S, Hedtfeld S, Rodriguez Gonzalez C, Hoerning A, Lachmann N Int J Mol Sci. 2024; 25(12).

PMID: 38928073 PMC: 11203434. DOI: 10.3390/ijms25126367.


Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells.

Bulcaen M, Kortleven P, Liu R, Maule G, Dreano E, Kelly M Cell Rep Med. 2024; 5(5):101544.

PMID: 38697102 PMC: 11148721. DOI: 10.1016/j.xcrm.2024.101544.


References
1.
Zielenski J, Tsui L . Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet. 1995; 29:777-807. DOI: 10.1146/annurev.ge.29.120195.004021. View

2.
van Meegen M, Terheggen-Lagro S, van der Ent C, Beekman J . CFTR expression analysis in human nasal epithelial cells by flow cytometry. PLoS One. 2011; 6(12):e27658. PMC: 3233544. DOI: 10.1371/journal.pone.0027658. View

3.
Hell S, Wichmann J . Breaking the diffraction resolution limit by stimulated emission: stimulated-emission-depletion fluorescence microscopy. Opt Lett. 2009; 19(11):780-2. DOI: 10.1364/ol.19.000780. View

4.
Welsh M, Smith A . Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993; 73(7):1251-4. DOI: 10.1016/0092-8674(93)90353-r. View

5.
van Meegen M, Terheggen S, Koymans K, Vijftigschild L, Dekkers J, van der Ent C . CFTR-mutation specific applications of CFTR-directed monoclonal antibodies. J Cyst Fibros. 2013; 12(5):487-96. DOI: 10.1016/j.jcf.2012.12.005. View